General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Janssen Pharmaceuticals, Inc(SIGNIFICANT), Salix Pharmaceuticals, Ltd(MODEST), Boehringer Ingelheim Pharmaceuticals, Inc(SIGNIFICANT), Roivant(MODEST), Amgen Inc.(SIGNIFICANT), Cytokinetics(MODEST), Aventria(MODEST), Serb(MODEST), Johnson & Johnson(MODEST), AstraZeneca Pharmaceuticals(MODEST)

View Full Disclosure